2m 2m 2m 2m 2m 2m 2m
UFP Technologies (UFPT)
NASDAQ
$234.68+$0.20 (+0.09%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.8BMarket Cap
- 0.07%1-Year Change
- Medical DevicesIndustry
UFP Technologies (UFPT)
$234.68+$0.20 (+0.09%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 602.8M +19.50% | 504.4M +26.08% | 400.1M +13.08% | 353.8M +71.48% | |
Cost of Revenue | 432.4M +20.87% | 357.7M +24.28% | 287.8M +9.23% | 263.5M +69.79% | |
Gross Profit | 170.4M +16.17% | 146.7M +30.71% | 112.2M +24.34% | 90.3M +76.59% | |
Sales and Marketing Expense | 77.4M +24.46% | 62.2M +22.26% | 50.9M +11.12% | 45.8M +55.35% | |
Research and Development Expense | -8.6M -17.31% | -10.4M +44.44% | -7.2M -177.42% | 9.3M +9.41% | |
Depreciation and Amortization Expense | 19.1M +30.14% | 14.7M +29.00% | 11.4M -4.03% | 11.9M +41.33% | |
Total Operating Expenses | 432.4M +20.87% | 357.7M +24.28% | 287.8M +9.23% | 263.5M +69.79% | |
Operating Profit | 92.3M +14.14% | 80.9M +40.29% | 57.7M +4.09% | 55.4M +161.10% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -8.1M +121.15% | -3.6M +31.92% | -2.8M +3,039.77% | |
Interest Income and Expense and Net | 0 +100.00% | -8.1M +121.15% | -3.6M -231.92% | 2.8M +5,538.78% | |
Total Nonoperating Income and Expense | -21,000 -111.11% | 189,000 +261.54% | -117,000 -244.44% | 81,000 +211.54% | |
Income before Taxes | 82.5M +12.99% | 73.0M +35.48% | 53.9M +2.25% | 52.7M +148.61% | |
Income Taxes | 14.2M +1.11% | 14.0M +56.43% | 9.0M -17.85% | 10.9M +105.47% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 68.3M +15.82% | 59.0M +31.29% | 44.9M +7.50% | 41.8M +163.06% | |
Net Income from Continuing Operations Applicable to Common | 82.5M +12.99% | 73.0M +35.48% | 53.9M +2.25% | 52.7M +148.61% | |
Basic EPS and Net Income | 8.87 +15.34% | 7.69 +30.56% | 5.89 +6.70% | 5.52 +161.61% | |
Diluted EPS and Net Income | 8.75 +15.44% | 7.58 +30.02% | 5.83 +6.97% | 5.45 +160.77% | |
Basic Weighted Average Shares | 7.7M +0.48% | 7.7M +0.58% | 7.6M +0.79% | 7.6M +0.53% | |
Diluted Weighted Average Shares | 7.8M +0.24% | 7.8M +1.09% | 7.7M +0.50% | 7.7M +0.63% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 20.3M +50.94% | 13.4M +155.56% | 5.3M +18.24% | 4.5M -59.96% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 20.3M +50.94% | 13.4M +155.56% | 5.3M +18.24% | 4.5M -59.96% | |
Total Current Assets | 201.0M +3.11% | 194.9M +34.79% | 144.6M +24.31% | 116.3M +33.24% | |
Accumulated Depreciation | 73.3M +13.94% | 64.4M +12.56% | 57.2M +8.73% | 52.6M -25.15% | |
Property and Plant and Equipment and Net | 79.1M +12.11% | 70.6M +13.56% | 62.1M +7.00% | 58.1M +2.66% | |
Total Long-Term Assets | 3.4M +670.47% | 447,000 -4.69% | 469,000 -87.10% | 3.6M +229.95% | |
Total Assets | 655.1M +4.15% | 629.0M +55.64% | 404.1M +6.86% | 378.2M +13.19% | |
Income Taxes Payable | 9.2M +161.75% | 3.5M +722.20% | 428,000 -79.91% | 2.1M -48.95% | |
Total Short-Term Debt | 12.5M 0.00% | 12.5M +212.50% | 4.0M 0.00% | 4.0M 0.00% | |
Total Current Liabilities | 74.9M -1.88% | 76.3M +31.07% | 58.2M +4.02% | 56.0M +61.24% | |
Total Long-Term Debt | 123.0M -30.48% | 176.9M +531.70% | 28.0M -45.10% | 51.0M -28.17% | |
Total Long-Term Liabilities | 3.5M -68.37% | 11.1M -26.59% | 15.2M -16.68% | 18.2M -5.41% | |
Total Liabilities | 231.2M -19.23% | 286.2M +142.48% | 118.0M -16.07% | 140.6M +0.69% | |
Retained Earnings | 374.8M +22.29% | 306.5M +23.83% | 247.5M +22.17% | 202.6M +25.99% | |
Total Stockholders Equity | 423.9M +23.67% | 342.8M +19.81% | 286.1M +20.44% | 237.5M +22.17% | |
Total Shares Outstanding | 7.7M +0.48% | 7.7M +0.48% | 7.6M +0.77% | 7.6M +0.62% | |
Cash Flow | |||||
Cash from Operating Activities | 91.9M +38.01% | 66.6M +61.11% | 41.3M +132.95% | 17.7M +24.14% | |
Capital Expenditures | 0 -100.00% | 9.7M -7.95% | 10.5M -23.88% | 13.8M +155.42% | |
Cash from Investing Activities | -27.6M -86.87% | -210.2M +1,903.85% | -10.5M -912.39% | 1.3M +101.27% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -58.2M -138.16% | 152.4M +607.57% | -30.0M +15.95% | -25.9M -134.97% | |
Financials Ratio | |||||
Gross Margin | 28.27% -2.79% | 29.08% +3.67% | 28.05% +9.95% | 25.51% +2.98% | |
Operating Margin | 15.32% -4.49% | 16.04% +11.27% | 14.41% -7.95% | 15.66% +52.26% | |
Return on Assets | 10.64% -6.81% | 11.42% -0.58% | 11.48% -2.12% | 11.73% +98.43% | |
Return on Equity | 17.82% -4.99% | 18.76% +9.32% | 17.16% -11.31% | 19.35% +126.12% | |
Revenue Growth | 19.50% -25.23% | 26.08% +99.39% | 13.08% -81.70% | 71.48% +375.79% | |
Current Ratio | 2.69 +5.08% | 2.56 +2.83% | 2.48 +19.51% | 2.08 -17.36% | |
Cash Ratio | 0.27 +53.83% | 0.18 +95.02% | 0.09 +13.71% | 0.08 -75.18% | |
Debt-to-Equity Ratio | 0.32 -42.15% | 0.55 +393.74% | 0.11 -51.66% | 0.23 -39.98% | |
Debt-to-Assets Ratio | 0.21 -31.32% | 0.30 +280.18% | 0.08 -45.53% | 0.15 -35.23% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow